Who Paid My Doc Search
Menu
Organisation paid for research Program year 2021 Source: CMS Open Payments

US Oncology Specialty

Neither a doctor nor a teaching hospital

Research payments

$2,780,708

3 payments

Through program year 2021, US Oncology Specialty is reported as receiving $2,780,708 in research payments, across 3 payments.

By program year

3 rows
Year Kind Amount Payments
2021 Research $759,292 1
2020 Research $942,403 1
2019 Research $1,079,013 1

Breakdown

Who paid Research payments · program years 2019–2021
  1. Novartis Pharmaceuticals Corporation $2,780,708 3 payments
Studies the money was for Research payments · program years 2019–2021
  1. Randomized Phase II Study of Miracle Mouth Wash Plus Hydrocortisone Versus Prednisolone Mouth Rinse to Prevent Everolimus Associated Stomatitis in Postmenopausal Women With Metatastic Breast Cancer MBC $2,780,708 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record